DocDollars

Amgen Inc.

CA · United States · Reporting entity ID 100000000203

Total reported 2019–2025
$2.38B
#10 of 2,960 reporting companies — 2.9% of all reported industry payments
$235.1M in general payments across 2,746,859 records, plus $2.15B in research funding across 37,108 records.

How it breaks down

General payments $235,085,390
Research funding $2,147,348,515

Where this comes from

Figures are from the CMS Open Payments “payments grouped by reporting entity” dataset, queried live. Reporting entities are applicable manufacturers and group purchasing organisations required to report under the Sunshine Act.

Summary

Amgen Inc. reported $2.38B to US doctors and teaching hospitals from 2019 to 2025, ranking #10 of 2,960 reporting companies. 90% of that was research funding and 10% general payments such as consulting, speaking, food and travel. 2,746,859 general payment records and 37,108 research records were filed.

Common questions about Amgen Inc.

How much has Amgen Inc. paid US doctors?

Amgen Inc. reported $2,382,433,905 to US physicians and teaching hospitals across the 2019–2025 Open Payments program years: $235,085,390 in general payments, $2,147,348,515 in research funding.

How does Amgen Inc. rank among drug and device companies?

It ranks #10 of 2,960 reporting entities by total reported value, about 2.9% of all industry payments in the dataset.

Does a payment from Amgen Inc. mean a doctor did something wrong?

No. Open Payments records transfers of value such as speaking fees, consulting, meals, travel and research funding. The data shows the relationship, not its effect on prescribing or care.